LoBuglio AF - Search Results

1

Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers.

Bonner JA, Raisch KP, Trummell HQ, Robert F, Meredith RF, Spencer SA, Buchsbaum DJ, Saleh MN, Stackhouse MA, LoBuglio AF, Peters GE, Carroll WR, Waksal HW. Bonner JA, et al. Among authors: lobuglio af. J Clin Oncol. 2000 Nov 1;18(21 Suppl):47S-53S. J Clin Oncol. 2000. PMID: 11060327

2

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.

Robert F, Ezekiel MP, Spencer SA, Meredith RF, Bonner JA, Khazaeli MB, Saleh MN, Carey D, LoBuglio AF, Wheeler RH, Cooper MR, Waksal HW. Robert F, et al. Among authors: lobuglio af. J Clin Oncol. 2001 Jul 1;19(13):3234-43. doi: 10.1200/JCO.2001.19.13.3234. J Clin Oncol. 2001. PMID: 11432891 Clinical Trial.

3

Chemotherapy tolerance after radioimmunotherapy with 90Y-CC49 monoclonal antibody in patients with advanced non-small cell lung cancer: clinical effects and hematologic toxicity.

Robert F, Busby EM, LoBuglio AF. Robert F, et al. Among authors: lobuglio af. Cancer Biother Radiopharm. 2003 Jun;18(3):317-25. doi: 10.1089/108497803322285071. Cancer Biother Radiopharm. 2003. PMID: 12954119 Clinical Trial.

4

TRAIL receptor-targeted therapy.

Buchsbaum DJ, Zhou T, Lobuglio AF. Buchsbaum DJ, et al. Among authors: lobuglio af. Future Oncol. 2006 Aug;2(4):493-508. doi: 10.2217/14796694.2.4.493. Future Oncol. 2006. PMID: 16922616 Review.

5

TRAIL-receptor antibodies as a potential cancer treatment.

Buchsbaum DJ, Forero-Torres A, LoBuglio AF. Buchsbaum DJ, et al. Among authors: lobuglio af. Future Oncol. 2007 Aug;3(4):405-9. doi: 10.2217/14796694.3.4.405. Future Oncol. 2007. PMID: 17661715 Review.

6

Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.

Meredith RF, Buchsbaum DJ, Alvarez RD, LoBuglio AF. Meredith RF, et al. Among authors: lobuglio af. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5643s-5645s. doi: 10.1158/1078-0432.CCR-07-0985. Clin Cancer Res. 2007. PMID: 17875801 Review.

7

Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.

Oliver PG, LoBuglio AF, Zinn KR, Kim H, Nan L, Zhou T, Wang W, Buchsbaum DJ. Oliver PG, et al. Among authors: lobuglio af. Clin Cancer Res. 2008 Apr 1;14(7):2180-9. doi: 10.1158/1078-0432.CCR-07-1392. Clin Cancer Res. 2008. PMID: 18381960 Free PMC article.

8

A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.

Posey JA, Ng TC, Yang B, Khazaeli MB, Carpenter MD, Fox F, Needle M, Waksal H, LoBuglio AF. Posey JA, et al. Among authors: lobuglio af. Clin Cancer Res. 2003 Apr;9(4):1323-32. Clin Cancer Res. 2003. PMID: 12684400 Clinical Trial.

9

Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.

Buchsbaum DJ, Zhou T, Grizzle WE, Oliver PG, Hammond CJ, Zhang S, Carpenter M, LoBuglio AF. Buchsbaum DJ, et al. Among authors: lobuglio af. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3731-41. Clin Cancer Res. 2003. PMID: 14506165

10

Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer.

Nowsheen S, Bonner JA, Lobuglio AF, Trummell H, Whitley AC, Dobelbower MC, Yang ES. Nowsheen S, et al. Among authors: lobuglio af. PLoS One. 2011;6(8):e24148. doi: 10.1371/journal.pone.0024148. Epub 2011 Aug 30. PLoS One. 2011. PMID: 21912620 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters